Uptake of Biogen’s breakthrough Alzheimer’s drug, Leqembi, appears to be picking up, with roughly $40 million in sales for the quarter.
Schlagwort-Archiv: Markets
Moderna stock falls more than 15% as it slashes guidance on low EU sales, tough U.S. vaccine market
Moderna now expects 2024 product revenue to come in between $3 billion and $3.5 billion, down from a previous guidance of $4 billion.
Barclays profit dips in the second quarter, beats estimates
The British lender is undergoing a major restructuring program in a bid to boost profits.
Shell beats second-quarter profit expectations, launches $3.5 billion share buyback program
Shell on Thursday posted stronger-than-expected second-quarter profit after issuing a warning over lower fossil fuel prices and refining margins.
Here’s everything you need to know about the Fed decision coming Wednesday
This week’s Federal Reserve meeting might not have much bearing on the present but potentially it could have a lot to do with the future.
Boeing reports wider-than-expected loss, weaker revenue
Boeing reported a bigger loss than expected for the second quarter and lower revenue as both its commercial airplane and defense programs continued to struggle.
HSBC shares rise 3% after profit beat, $3 billion buyback announcement
HSBC posted a narrow decline in pretax profit in the first half of the year, but beat expectations on the back of a high-interest rate environment.
We’re upgrading Microsoft after earnings. The stock has pulled back enough lately
We were so close to having an encore of the picture-perfect results we got in Microsoft’s prior quarter.
Starbucks‘ turnaround takes an encouraging step forward. Here’s what we want to see next
Starbucks has a long way to go in its turnaround, but Tuesday night’s better-than-feared results are an encouraging step forward.
AMD jumps on earnings report that validates our decision to reinvest in the stock
AMD shares are getting a much-needed lift after the chipmaker upped the forecast for its AI business.